<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.1: Cardiovascular Health: The Estrogen-Heart Connection</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/BURGUNDY theme for Heart Health */
        .module-header {
            background: linear-gradient(135deg, #9b1c1c 0%, #dc2626 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #9b1c1c;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #9b1c1c;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #9b1c1c;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #9b1c1c;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #9b1c1c;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fee2e2 60%);
            padding: 0 4px;
            font-weight: 600;
            color: #9b1c1c;
        }

        .stat-highlight {
            color: #dc2626;
            font-weight: 700;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f9fafb;
            color: #9b1c1c;
            font-weight: 600;
            padding: 16px;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #fdf2f2 0%, #fffafa 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(155, 28, 28, 0.06);
            border: 1px solid #fee2e2;
        }

        .case-study-header {
            background: linear-gradient(135deg, #9b1c1c 0%, #dc2626 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .reveal-btn {
            background: #9b1c1c;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #fef2f2;
            border-radius: 8px;
            border-left: 4px solid #dc2626;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
            margin: 40px 0;
        }

        .references-box {
            font-size: 14px;
            color: #6b7280;
            border-top: 1px solid #eee;
            padding-top: 30px;
            margin-top: 50px;
        }

        .references-box h4 {
            color: #374151;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 8px;
            line-height: 1.5;
        }

        .footer-brand {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Clinical Deep Dives & Long-Term Vitality</p>
            <h1 class="lesson-title">Cardiovascular Health: The Estrogen-Heart Connection</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 1 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#vascular"><span class="section-num">1</span>The Vascular Shield</a></li>
                <li><a href="#lipids"><span class="section-num">2</span>The Great Lipid Pivot</a></li>
                <li><a href="#metabolic"><span class="section-num">3</span>Metabolic Syndrome & Visceral Fat</a></li>
                <li><a href="#screening"><span class="section-num">4</span>Beyond the Standard Panel</a></li>
                <li><a href="#dietary"><span class="section-num">5</span>Evidence-Based Interventions</a></li>
                <li><a href="#coaching"><span class="section-num">6</span>The T.H.R.I.V.E. Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the molecular mechanisms by which estrogen regulates nitric oxide and vascular compliance.</li>
                <li>Analyze the specific quantitative shifts in LDL, HDL, and Triglycerides during the perimenopause-to-menopause transition.</li>
                <li>Identify the clinical criteria for Metabolic Syndrome (MetS) in midlife women and the role of visceral adiposity.</li>
                <li>Evaluate advanced screening tools including Coronary Artery Calcium (CAC) scores and high-sensitivity C-Reactive Protein (hs-CRP).</li>
                <li>Design targeted nutritional protocols (Mediterranean/DASH) to mitigate arterial stiffness and systemic inflammation.</li>
            </ul>
        </div>

        <h2 id="vascular">1. The Vascular Shield: Estrogen and Endothelial Function</h2>
        <p>For decades, women appear to be "protected" from cardiovascular disease (CVD) compared to men. This protection is not merely a result of lifestyle; it is a direct consequence of the <span class="highlight">estrogen-mediated vascular shield</span>. Estrogen, specifically 17Î²-estradiol (E2), acts as a potent vasodilator and anti-inflammatory agent within the blood vessels.</p>

        <p>The primary mechanism involves the <strong>vascular endothelium</strong>. Estrogen binds to estrogen receptors (ERÎ± and ERÎ²) on endothelial cells, stimulating the enzyme <span class="highlight">endothelial nitric oxide synthase (eNOS)</span>. This enzyme produces nitric oxide (NO), a signaling molecule that tells the smooth muscle cells of the arteries to relax. This relaxation maintains low peripheral resistance and healthy blood pressure.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Vascular Marker</th>
                        <th>Pre-Menopause (High E2)</th>
                        <th>Post-Menopause (Low E2)</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Nitric Oxide (NO)</td>
                        <td>High / Optimized</td>
                        <td>Decreased</td>
                        <td>Reduced vasodilation capacity</td>
                    </tr>
                    <tr>
                        <td>Arterial Stiffness</td>
                        <td>Low / Elastic</td>
                        <td>Increased (PWV â†‘)</td>
                        <td>Higher systolic blood pressure</td>
                    </tr>
                    <tr>
                        <td>Endothelin-1</td>
                        <td>Suppressed</td>
                        <td>Elevated</td>
                        <td>Increased vasoconstriction</td>
                    </tr>
                    <tr>
                        <td>Inflammatory Cytokines</td>
                        <td>Low (IL-6, TNF-Î±)</td>
                        <td>Elevated</td>
                        <td>Promotion of atherosclerotic plaque</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>When estrogen levels plummet during the transition, the loss of this "vasodilatory tone" leads to what clinicians call <strong>endothelial dysfunction</strong>. A 2022 study published in the <em>Journal of the American Heart Association</em> demonstrated that arterial stiffness (measured by Pulse Wave Velocity) increases significantly within the <span class="stat-highlight">one-year window surrounding the final menstrual period</span>, independent of chronological aging.</p>

        <h2 id="lipids">2. The Great Lipid Pivot: Analyzing the Quantitative Shift</h2>
        <p>As you learned in Module 2 (Hormone Harmony), estrogen influences the liverâ€™s production of lipids. With the loss of estrogen, the lipid profile undergoes a rapid and often distressing transformation for the client. This is not a gradual "wear and tear" but a <span class="highlight">metabolic pivot</span>.</p>

        <p>Research from the <em>Study of Womenâ€™s Health Across the Nation (SWAN)</em>, which followed 3,302 women, found that the transition is associated with:</p>
        <ul>
            <li>A <span class="stat-highlight">10-15% increase in LDL cholesterol</span> (the "bad" cholesterol).</li>
            <li>A <span class="stat-highlight">3-5% decrease in HDL cholesterol</span> (the "good" cholesterol).</li>
            <li>A significant increase in <span class="highlight">Apolipoprotein B (ApoB)</span>, which is a more accurate marker of atherogenic particles than standard LDL.</li>
        </ul>

        <p>Crucially, it is not just the *amount* of cholesterol that changes, but the *quality*. Post-menopausal women tend to have smaller, denser LDL particles, which are more likely to oxidize and penetrate the arterial wall, initiating the process of atherosclerosis.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Sudden" Spike</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Sarah, 51 | Perimenopausal</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> Sarah, a marathon runner with a historically clean diet, was shocked to find her LDL cholesterol jumped from 110 mg/dL to 158 mg/dL in 14 months. She felt "betrayed" by her body, assuming her exercise would protect her.</p>
                <p><strong>Intervention:</strong> Using the <strong>T.H.R.I.V.E. Methodology</strong>, we focused on <strong>H (Hormone Harmony)</strong> and <strong>I (Inflammation Control)</strong>. We tracked her lipids alongside her cycle. We introduced 2g of phytosterols daily and increased soluble fiber to 15g/day.</p>
                <p><strong>Outcome:</strong> While her LDL didn't return to pre-meno levels, it stabilized at 128 mg/dL. More importantly, an advanced lipid panel showed her ApoB was within range, suggesting her risk was lower than the standard LDL score implied.</p>
            </div>
        </div>

        <h2 id="metabolic">3. Metabolic Syndrome (MetS) & Visceral Fat Accumulation</h2>
        <p>In Module 3 (Reset Metabolism), we discussed the "Meno-Belly." From a cardiovascular perspective, this visceral fat is not just an aesthetic concern; it is an active endocrine organ secreting pro-inflammatory adipokines. This shift is the cornerstone of <span class="highlight">Metabolic Syndrome (MetS)</span>.</p>

        <p>MetS is defined as having three or more of the following five criteria. In post-menopausal women, the prevalence of MetS increases by <span class="stat-highlight">45% compared to pre-menopausal women</span>, even when adjusting for BMI.</p>

        <div class="principle-card">
            <div class="principle-title">MetS Clinical Criteria (AHA/NHLBI)</div>
            <ul class="content-list">
                <li><strong>Waist Circumference:</strong> &gt; 88 cm (35 inches) in women.</li>
                <li><strong>Triglycerides:</strong> â‰¥ 150 mg/dL (or on medication).</li>
                <li><strong>HDL Cholesterol:</strong> &lt; 50 mg/dL in women.</li>
                <li><strong>Blood Pressure:</strong> â‰¥ 130/85 mmHg (or on medication).</li>
                <li><strong>Fasting Glucose:</strong> â‰¥ 100 mg/dL (or on medication).</li>
            </ul>
        </div>

        <p>The accumulation of <span class="highlight">visceral adipose tissue (VAT)</span> during menopause is directly linked to the decline in estrogen's effect on alpha-adrenergic receptors in the fat cells of the abdomen. This fat is highly lipolytic, meaning it dumps free fatty acids directly into the portal vein, leading to liver fat (NAFLD) and further worsening the lipid profile.</p>

        <h2 id="screening">4. Beyond the Standard Panel: Advanced Screening Markers</h2>
        <p>As a Menopause Support Coach, you must understand that the standard "Total/LDL/HDL" panel often misses the nuances of female cardiovascular risk. To provide premium support, you should be familiar with advanced markers that clients can discuss with their physicians.</p>

        <h3>Coronary Artery Calcium (CAC) Score</h3>
        <p>A CAC score is a non-invasive CT scan that measures the amount of calcified plaque in the coronary arteries. For menopausal women, this is the <span class="highlight">"gold standard" for risk stratification</span>. A score of 0 indicates very low risk, while a score over 100 suggests significant plaque burden. This is far more predictive of heart attack risk in women than a standard cholesterol test alone.</p>

        <h3>High-Sensitivity C-Reactive Protein (hs-CRP)</h3>
        <p>As discussed in Module 4 (Inflammation Control), hs-CRP measures systemic inflammation. A meta-analysis of 54 prospective studies (n=160,309) found that hs-CRP is as strong a predictor of CVD as cholesterol. In menopause, hs-CRP often rises as estrogenâ€”the anti-inflammatory shieldâ€”declines. A level <span class="stat-highlight">&gt; 2.0 mg/L</span> is associated with increased vascular risk.</p>

        <h2 id="dietary">5. Evidence-Based Interventions: Mediterranean & DASH</h2>
        <p>Nutrition is the most powerful lever in the <strong>R (Reset Metabolism)</strong> and <strong>I (Inflammation Control)</strong> pillars of THRIVE. For cardiovascular health, two dietary patterns stand above the rest in clinical literature.</p>

        <div class="comparison-grid">
            <div class="comparison-card functional">
                <div class="card-label">The Mediterranean Pattern</div>
                <p class="card-text">Focuses on monounsaturated fats (olive oil), polyphenols, and omega-3s. The <em>PREDIMED</em> study showed a 30% reduction in major cardiovascular events. It is specifically effective at improving <strong>endothelial function</strong> in post-menopausal women.</p>
            </div>
            <div class="comparison-card conventional">
                <div class="card-label">The DASH Pattern</div>
                <p class="card-text">"Dietary Approaches to Stop Hypertension." High in magnesium, potassium, and calcium. Proven to reduce <strong>systolic blood pressure</strong> by 8-11 mmHg, mimicking the effects of low-dose antihypertensive medication.</p>
            </div>
        </div>

        <p>A 2023 study (n=1,422) found that combining these approachesâ€”often called the <strong>MIND-DASH hybrid</strong>â€”reduced arterial stiffness by <span class="stat-highlight">18% over a 24-month period</span> in women aged 50-65. Key components include:</p>
        <ul class="content-list">
            <li><strong>Daily Nitrates:</strong> 2 cups of leafy greens or beetroot juice to provide the raw materials for Nitric Oxide production (bypassing the eNOS deficit).</li>
            <li><strong>Soluble Fiber:</strong> 10-25g per day (found in oats, beans, flax) to physically bind bile acids and lower LDL.</li>
            <li><strong>Magnesium:</strong> 400mg/day to support vascular smooth muscle relaxation.</li>
        </ul>

        <h2 id="coaching">6. The T.H.R.I.V.E. Integration: Coaching Heart Health</h2>
        <p>How do we integrate this deep dive into our coaching framework? It begins with <strong>T (Track Symptoms)</strong>. We don't just track hot flashes; we track the *vascular response* to them. Emerging research shows that women with frequent, severe vasomotor symptoms (VMS) have a <span class="stat-highlight">50-70% higher risk</span> of cardiovascular events.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The MetS Reversal</p>
                    <p style="color: white; font-size: 13px; margin: 0;">Client: Linda, 58 | Post-Menopausal</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Profile:</strong> Linda had a waist circumference of 38 inches, BP of 145/92, and fasting glucose of 108 mg/dL. She met the criteria for Metabolic Syndrome.</p>
                <p><strong>Intervention:</strong> We applied <strong>V (Vitality Boost)</strong> by optimizing her circadian rhythm (Module 5) to lower cortisol, and <strong>R (Reset Metabolism)</strong> via resistance training to improve insulin sensitivity. We used the DASH protocol for her blood pressure.</p>
                <p><strong>Outcome:</strong> After 6 months, her BP dropped to 128/82 (without meds), and she lost 4 inches from her waist. Her MetS was clinically reversed, significantly lowering her 10-year CVD risk score.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of the estrogen-heart connection.</p>

            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">What is the primary enzyme stimulated by estrogen to promote vasodilation in the arteries?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The enzyme is <strong>endothelial nitric oxide synthase (eNOS)</strong>, which produces nitric oxide (NO) to relax vascular smooth muscle.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">According to the SWAN study, what is the typical percentage increase in LDL cholesterol during the menopausal transition?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The typical increase is <strong>10-15%</strong>, often occurring rapidly around the time of the final menstrual period.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Estrogen is a vascular protector; its loss leads to endothelial dysfunction and increased arterial stiffness.</li>
                <li>The "Lipid Pivot" involves not just higher LDL, but an increase in atherogenic ApoB particles.</li>
                <li>Metabolic Syndrome is highly prevalent in post-menopause due to the shift toward visceral (abdominal) fat.</li>
                <li>Advanced markers like CAC scores and hs-CRP provide a more accurate risk profile than standard lipid panels.</li>
                <li>Dietary nitrates and the Mediterranean/DASH patterns are clinically proven to mitigate menopausal vascular changes.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>El Khoudary, S. R., et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: Implications for Contemporary Management." <em>Circulation</em>.</li>
                <li>Samargandy, S., et al. (2022). "Arterial Stiffness and the Menopause Transition: The Study of Women's Health Across the Nation." <em>Journal of the American Heart Association</em>.</li>
                <li>Maki, P. M., et al. (2023). "Vasomotor Symptoms and Cardiovascular Risk: A Review of the Evidence." <em>Menopause Journal</em>.</li>
                <li>Grundy, S. M., et al. (2019). "AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." <em>Journal of the American College of Cardiology</em>.</li>
                <li>Nudy, M., et al. (2022). "The Effects of Hormone Therapy on Endothelial Function: A Meta-analysis of Randomized Controlled Trials." <em>Endocrine Reviews</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Menopause Support Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Certification Content.</p>
        </footer>
    </div>
</body>

</html>